Q1 2026 Management View "During the first quarter, we reached an agreement to divest certain GI products. And in April, we reached a second agreement to divest our remaining GI products." (President, ...
Smoke evacuation growth is increasingly driven by direct sales where CONMED controls the customer relationship, intentionally ...
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales ...
Zacks Investment Research on MSN
CONMED's Q1 earnings and revenues beat, organic sales outlook up
CONMED Corporation CNMD posted adjusted earnings per share (EPS) of 89 cents for the first quarter of 2026, down 6.3% year ...
CONMED Corporation reshapes its healthcare strategy with strong earnings, refined focus, and evolving market sentiment within ...
We think that DENTSPLY stock (NASDAQ NDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for ...
NEW YORK (Reuters) - Activist investor Voce Capital Management LLC is pushing ConMed Corp (NSQ:CNMD) to pursue a sale, saying it believes the surgical-device maker could attract buyout interest from ...
We think that Stryker Corporation currently is a better bet compared to Conmed Corp. CNMD stock trades at 4x trailing revenues, lower than that of SYK, whose P/S multiple stands at 6.1x. Does this gap ...
CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General Surgery ...
CONMED stock draws attention as healthcare technology trends evolve, highlighting company developments, institutional activity, and sector positioning within the broader medical device landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results